![]() |
市场调查报告书
商品编码
1828170
2025年全球智慧注射器市场报告Smart Syringe Global Market Report 2025 |
||||||
近年来,智慧注射器市场规模强劲成长,从2024年的111.4亿美元成长到2025年的121.5亿美元,复合年增长率为9.0%。预测期内的增长归因于药品安全需求、血源性疾病流行、法规遵从性、全球疫苗接种计划以及医疗保健意识的不断提高。
预计未来几年智慧注射器市场将快速成长,到2029年将达到190.2亿美元,复合年增长率为11.9%。预测期内的成长主要受以下因素驱动:全球疫苗接种工作、用药错误预防、慢性病增多、家庭医疗保健的扩展以及政府医疗保健计划。预测期内的主要趋势包括合作与伙伴关係、监管回应、疫苗接种计划的采用、对永续材料的关注以及新兴市场的扩张。
智慧注射器是整合先进技术的尖端医疗设备,旨在提升注射的安全性、准确性和效率。这些创新註射器有效解决了针刺伤、用药错误以及血液感染疾病传播等关键问题,显着提高了病患和医护人员的安全。
智慧注射器的主要类别包括自动停用注射器、主动安全注射器和被动安全注射器。自动停用注射器经过特别设计,可防止单次注射后重复使用。这些注射器广泛应用于疫苗宣传活动,一次使用后即可自动锁定,确保安全无污染的给药。这种多功能解决方案适用于包括儿童和成人在内的各个群体,并可用于药物输送、疫苗接种和检体采样。自动拆卸注射器应用于各种行业,包括医院、健康维护组织 (HMO)、糖尿病患者照护、家庭医学和精神病学。
2025年美国关税的大幅上调及其引发的贸易摩擦,对医疗设备产业产生了重大影响,尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制价格上涨,製造商面临利润压力。监管挑战使情况更加复杂,因为由于关税而更换供应商通常需要重新认证医疗设备,导致市场进入延迟。为此,企业正在透过双重采购关键零件、增加标准产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司 (The Business Research Company) 最新报告系列之一,提供智慧注射器市场统计数据,例如全球市场规模、区域份额、竞争对手的智慧注射器市场份额、详细的智慧注射器细分市场、市场趋势、商业机会以及在智慧注射器行业取得成功所需的其他数据。这份智慧注射器市场研究报告对该行业的现状和未来情况进行了详细分析,为您提供所需的一切全面观点。
未来五年的预测成长率为11.9%,较我们先前对该市场的预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。这种影响将透过对主要由法国和丹麦供应的剂量控制微处理器和自动覆盖机制征收关税直接影响美国,并可能增加安全药物传输系统的成本。由于互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响,这种影响可能会更加广泛。
预计未来几年,不断增长的医疗支出将推动智慧注射器市场的成长。医疗支出代表国家、组织和个人投入医疗服务和产品的总资源,通常以货币量化。支出的成长受到多种因素的影响,包括人口老化、慢性病的流行、医疗技术的进步以及消费者对优质照护不断提高的期望。智慧注射器市场正在透过提供创新解决方案来应对这种成长,这些解决方案可增强病患安全性、提高手术效率并降低与传统注射器併发症相关的医疗成本。例如,非营利加拿大卫生资讯研究所预测,到 2023 年 11 月,加拿大的医疗总支出将达到 3,440 亿美元,年增 2.8%。因此,医疗支出的成长正在推动智慧注射器市场的扩张。
预计血源性疾病的日益普及将在未来几年推动智慧注射器市场的成长。血液传染疾病是由病原体引起的感染疾病,透过接触受感染的血液或体液传播。智慧注射器配备了一次性使用后自动停止推桿的装置,可降低意外针刺的风险,并提供一种有效的工具来对抗这些疾病。例如,2024 年 4 月,美国公共卫生机构疾病管制与预防中心 (CDC) 报告称,2022 年有 2,126 例急性乙型肝炎病例。这比 2021 年报告的 2,045 例有所增加,估计感染率约为 13,300。因此,血源性疾病的兴起正在刺激智慧注射器市场的扩张。
随着领先公司推出安全注射器等新产品,智慧注射器市场正在经历日益增长的产品创新,以增强患者安全性,最大限度地降低针刺伤风险,并提高手术效率。安全注射器经过专门设计,旨在降低针刺伤的可能性并防止注射器重复使用。例如,2024年4月,印度医疗设备公司印度斯坦注射器和医疗器材公司(Hindustan Syringes and Medical Devices)推出了Dispojekt注射器,这是一款旨在增强医疗环境安全性的安全注射器。 Dispojekt采用透明的单手安全机制,可减少意外针刺伤(NSI),这是医护人员血液传染疾病的常见原因。注射器还配有模压塑胶安全防护罩,可防止使用过程中血液飞溅,为患者和医护人员创造更安全的环境。透过解决关键的安全和感染控制问题,Dispojekt体现了HMD对品质和创新的承诺,并支持印度成为全球医疗製造领导者的目标。
智慧注射器市场前沿的企业正积极投资技术进步,并融入近距离场通讯(NFC) 技术等创新技术,以提升竞争优势。 NFC 是一种近距离无线通讯技术,可促进装置之间的非接触式资料交换。法国医疗设备製造商 NP Plastibell 于 2022 年 5 月推出预填充智慧注射器,体现了这一趋势。这款智慧注射器内建 NFC 晶片,可将重要的用药资讯传达给医生和患者。 NFC 晶片储存药品名称、剂量、有效期限和批号等关键讯息,方便透过智慧型手机和其他支援 NFC 的装置存取。
2022年7月,美国知名医疗设备製造商Sharps Technology以250万美元收购了Safeguard Medical的智慧注射器生产工厂。此次收购旨在扩大Sharps的生产能力,并满足日益增长的智慧注射器需求。 Safeguard Medical是一家专注于智慧注射器和急救医疗技术的美国製造商,在当前充满活力的市场环境中,为Sharps Technology的成长策略做出了贡献。
智慧注射器市场的主要参与者包括 Becton Dickinson and Company、Gerresheimer AG、Baxter International Inc.、Terumo Corporation、Braun Melsungen AG、Cardinal Health Inc.、Smiths Medical Inc.、Retractable Technologies Inc.、AdvaCare Pharma、Numedico Technologies Pty Ltd.、Merit Technology Inc. AG、Vetter Pharma International GmbH、Catalent Inc.、Thermo Fisher Scientific Inc.、Haselmeier GmbH、Owen Mumford Ltd.、Ypsomed Holding AG、威高集团、江苏汇达医疗器材有限公司及山东威高集团医用高分子有限公司。
2024年,北美是全球智慧注射器市场最大的地区。预计亚太地区将成为预测期内成长最快的地区。智慧注射器市场报告涵盖亚太地区、西欧、东欧、北美、南美以及中东和非洲。
智慧注射器市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、英国、美国、义大利和西班牙。
智慧注射器市场包括可替换针头注射器和固定针头注射器的销售。该市场的价值是「工厂门口」价值,即商品製造商或创造者出售的商品的价值,无论是出售给其他营业单位(包括下游製造商、批发商、经销商和零售商)还是直接出售给最终客户。该市场中的商品价值还包括商品创造者出售的任何相关服务。
Smart syringes represent cutting-edge medical devices that integrate technology to enhance the safety, precision, and efficiency of administering injections. These innovative syringes effectively address critical concerns such as needlestick injuries, medication errors, and the transmission of bloodborne diseases, thereby significantly improving both patient and healthcare provider safety.
The primary categories of smart syringes include auto-disable syringes, active safety syringes, and passive safety syringes. Auto-disable syringes are specifically engineered to prevent reuse after a single injection. Widely employed in immunization campaigns, these syringes automatically lock after a single use, ensuring the secure and contamination-free delivery of doses. This versatile solution caters to various segments, including pediatrics and adults, and finds applications in drug delivery, vaccination, and blood specimen collection. Auto-disable syringes are utilized across diverse industries, including hospitals, health maintenance organizations (HMOs), diabetic patient care, family practices (physicians), psychiatry, and more.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The smart syringes market research report is one of a series of new reports from The Business Research Company that provides smart syringes market statistics, including smart syringes industry global market size, regional shares, competitors with a smart syringes market share, detailed smart syringes market segments, market trends, and opportunities, and any further data you may need to thrive in the smart syringes industry. These smart syringes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The smart syringe market size has grown strongly in recent years. It will grow from $11.14 billion in 2024 to $12.15 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to need for medication safety, prevalence of blood-borne diseases, regulatory compliance, global immunization programs, increased healthcare awareness.
The smart syringe market size is expected to see rapid growth in the next few years. It will grow to $19.02 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to global vaccination initiatives, prevention of medication errors, rise in chronic diseases, expansion of home healthcare, government healthcare initiatives. Major trends in the forecast period include collaborations and partnerships, regulatory compliance, adoption in vaccination programs, focus on sustainable materials, expansion in emerging markets.
The forecast of 11.9% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on dose-control microprocessors and auto-disable mechanisms, primarily sourced from France and Denmark, increasing costs for safe medication administration systems.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
Increasing healthcare expenditure is anticipated to drive the growth of the smart syringes market in the coming years. Healthcare expenditure represents the total resources, usually quantified in monetary terms, that a country, organization, or individual dedicates to healthcare services and products. This rise in spending is influenced by various factors, including an aging population, the prevalence of chronic diseases, advancements in medical technology, and growing consumer expectations for high-quality care. The smart syringes market aligns with this increased expenditure by offering innovative solutions that enhance patient safety, improve procedural efficiency, and lower healthcare costs related to complications from traditional syringes. For example, in November 2023, the Canadian Institute for Health Information, a non-profit organization, projected total health spending in Canada to reach $344 billion for the year, a 2.8% increase over the prior year. Thus, the growth in healthcare expenditure is fueling the expansion of the smart syringes market.
The rising prevalence of blood-borne diseases is expected to drive the growth of the smart syringes market in the coming years. Blood-borne diseases are infections caused by pathogens transmitted through contact with infected blood or bodily fluids. Smart syringes offer an effective tool in combating these diseases, featuring a mechanism that automatically disables the plunger after a single use, thus reducing the risk of accidental needle sticks. For example, in April 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based public health agency, reported 2,126 acute hepatitis B cases in 2022, equating to an estimated 13,800 infections after accounting for underreporting. This marks an increase from 2021, which had 2,045 reported cases and approximately 13,300 estimated infections. Consequently, the growing prevalence of blood-borne diseases is fueling the expansion of the smart syringes market.
Product innovations are increasingly popular in the smart syringes market, as major companies introduce new products like safety syringes to enhance patient safety, minimize needlestick injury risks, and boost procedural efficiency. Safety syringes are specifically designed to lower the chance of needlestick injuries and prevent syringe reuse. For instance, in April 2024, Hindustan Syringes and Medical Devices, an India-based medical device company, launched Dispojekt Syringes, a safety syringe designed to enhance safety in healthcare settings. Dispojekt features a transparent, one-hand-operable safety mechanism to reduce accidental needlestick injuries (NSIs), a common source of blood-borne disease transmission among healthcare professionals. The syringe also includes a molded plastic safety shield to prevent blood splatter during use, fostering a safer environment for both patients and healthcare workers. By addressing critical safety and infection control concerns, Dispojekt reflects HMD's commitment to quality and innovation, supporting India's goal of becoming a global leader in medical manufacturing.
Companies at the forefront of the smart syringes market are actively investing in technological advancements, incorporating innovations such as Near Field Communication (NFC) technology to gain a competitive advantage. NFC is a short-range wireless communication technology facilitating contactless data exchange between devices. NP Plastibell, a France-based medical device manufacturer, exemplifies this trend with the launch of its Pre-filled Smart Syringe in May 2022. This smart syringe incorporates an embedded NFC chip that transmits essential information about the medication to both practitioners and patients. The NFC chip stores crucial details, including drug name, dosage, expiration date, and lot number, allowing easy access through smartphones or other NFC-enabled devices.
In July 2022, Sharps Technology, a prominent US-based medical device manufacturer, acquired Safeguard Medical's smart syringes manufacturing facility for $2.5 million. This acquisition is aimed at expanding Sharps' manufacturing capabilities to meet the rising demand for smart syringes. Safeguard Medical, a US-based manufacturer specializing in smart syringes and emergency medical technologies, contributes to Sharps Technology's growth strategy in this dynamic market landscape.
Major companies operating in the smart syringe market include Becton Dickinson and Company, Gerresheimer AG, Baxter International Inc., Terumo Corporation, Braun Melsungen AG, Cardinal Health Inc., Smiths Medical Inc, Retractable Technologies Inc., AdvaCare Pharma, Numedico Technologies Pty Ltd., Merit Medical Systems Inc., Nipro Corporation, Revolutions Medical Corporation, Sharps Technology, West Pharmaceutical Services Inc., Schott AG, Vetter Pharma International GmbH, Catalent Inc., Thermo Fisher Scientific Inc., Haselmeier GmbH, Owen Mumford Ltd., Ypsomed Holding AG, Weigao Group, Jiangsu Huida Medical Instruments Co. Ltd., Shandong Weigao Group Medical Polymer Co. Ltd.
North America was the largest region in the global smart syringes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart syringe market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the smart syringe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The smart syringes market consists of sales of exchangeable needle syringes and fixed needle syringes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Smart Syringe Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on smart syringe market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for smart syringe ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart syringe market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.